Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

2.

Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design.

Kohro T, Yamazaki T.

Hypertens Res. 2009 Feb;32(2):109-14. doi: 10.1038/hr.2008.26. Epub 2009 Jan 16. Review.

PMID:
19262468
3.
5.

The Captopril Prevention Project (CAPPP): description and status.

Hansson L.

Am J Hypertens. 1994 Sep;7(9 Pt 2):82S-83S.

PMID:
7818840
6.

Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.

Bulpitt C, Fletcher A, Beckett N, Coope J, Gil-Extremera B, Forette F, Nachev C, Potter J, Sever P, Staessen J, Swift C, Tuomilehto J.

Drugs Aging. 2001;18(3):151-64.

PMID:
11302283
7.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD.

Diabetes Care. 2000 Jul;23(7):888-92.

8.

Beyond HERS: some (not so) random thoughts on randomized clinical trials.

Bush T.

Int J Fertil Womens Med. 2001 Mar-Apr;46(2):55-9.

PMID:
11374656
9.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
10.

The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.

Ogihara T, Matsuzaki M, Matsuoka H, Shimamoto K, Shimada K, Rakugi H, Umemoto S, Kamiya A, Suzuki N, Kumagai H, Ohashi Y, Takishita S, Abe K, Saruta T; COPE Trial Group.

Hypertens Res. 2005 Apr;28(4):331-8. Review.

PMID:
16138563
11.
12.

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators.

Ann Intern Med. 2009 Mar 17;150(6):379-86.

PMID:
19293071
14.

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators.

Am Heart J. 2006 Sep;152(3):434-41.

PMID:
16923409
15.

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A; FEVER Study Group.

J Hypertens. 2005 Dec;23(12):2157-72.

PMID:
16269957
18.

Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.

Laufer E, Reid C, Qi XL, Jennings GL.

Clin Exp Pharmacol Physiol. 1998 Mar-Apr;25(3-4):208-15.

PMID:
9590570
19.

Vitamin E and heart disease: basic science to clinical intervention trials.

Pryor WA.

Free Radic Biol Med. 2000 Jan 1;28(1):141-64. Review.

PMID:
10656300
20.

The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.

Hansson L, Hedner T, Lindholm L, Niklason A, Luomanmäki K, Niskanen L, Lanke J, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE.

Blood Press. 1997 Nov;6(6):365-7.

PMID:
9495662

Supplemental Content

Support Center